[{"from": "human", "value": "Based on the given information, design a molecule that meets the desired specifications. The molecule is an oral bioenhancer that targets multiple drug resistance in tumors. In many cases, the appearance of multidrug resistance in cancer is due to a change in expression of protein inhibitors. As of August 2007 elacridar was not listed on GSK's product pipeline. Development is assumed to have been discontinued."}, {"from": "gpt", "value": "[C][O][C][=C][C][=C][C][=C][Ring1][=Branch1][N][C][=C][Branch1][Branch1][C][Ring1][=Branch1][=O][C][=C][C][=C][Ring1][Branch2][C][=Branch1][C][=O][N][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][C][N][C][C][C][=C][C][=Branch1][=N][=C][Branch1][Branch2][C][=C][Ring1][=Branch1][C][Ring1][#Branch2][O][C][O][C]"}]